| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.34 | 4e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0001 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |